CorFlow Therapeutics AG
PrivateLast Round
Series B
Sep 9, 2024
Total Funding Raised
$58.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CorFlow Therapeutics AG operates in Healthcare & Life Sciences and is based in Baar. Its latest recorded funding round was a Series B round in September 2024.
CorFlow Therapeutics AG is a medical technology company that develops diagnostic and therapeutic devices for the treatment of microvascular obstruction in heart attack patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorFlow Therapeutics AG Comparables
Compare CorFlow Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abbott Laboratories | 71% | |
| Medtronic | 71% | |
| Bracco S.p.A. | 67% |
For institutional investors. Book with your work email.
CorFlow Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 9, 2024 | ||||
| Seed | Sep 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CorFlow Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOFA Healthcare | Series B |
| 415 Capital | Series B |
| Unorthodox Ventures | Series B |
| Panakès Partners | Series B |
| Wellington Partners | Series B |
| M&L Healthcare | Series B |
| M&L Healthcare Investments | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 273% MoM, reaching 2.2K.
- Apr 1, 2026
Second generation CoFI system now in clinical trials.
For institutional investors. Book with your work email.
CorFlow Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CorFlow Therapeutics AG's valuation, stock price, and market status.
Is CorFlow Therapeutics AG a public or private company?
CorFlow Therapeutics AG is a private company.
What is the current stock price of CorFlow Therapeutics AG?
CorFlow Therapeutics AG is a private company, so its shares have no public market price. Caplight tracks CorFlow Therapeutics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CorFlow Therapeutics AG worth (valuation)?
Valuation information for CorFlow Therapeutics AG is not publicly available.
Can I buy CorFlow Therapeutics AG stock?
CorFlow Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CorFlow Therapeutics AG's last funding round?
CorFlow Therapeutics AG's most recent funding round was Series B on September 9, 2024.
Who are the main investors in CorFlow Therapeutics AG?
Key investors in CorFlow Therapeutics AG include Panakès Partners, Broadview Ventures.
Will CorFlow Therapeutics AG IPO soon?
No public IPO plans have been announced for CorFlow Therapeutics AG.
How can I track CorFlow Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades in CorFlow Therapeutics AG's shares on secondary markets.